| Ident. | Authors (with country if any) | Title |
|---|
| 000013 (2017) |
Dami Collier [Royaume-Uni] ; Collins Iwuji [Afrique du Sud, Royaume-Uni] ; Anne Derache [Afrique du Sud, France] ; Tulio De Oliveira [Afrique du Sud] ; Nonhlanhla Okesola [Afrique du Sud] ; Alexandra Calmy [Suisse] ; Francois Dabis [France] ; Deenan Pillay [Royaume-Uni, Afrique du Sud] ; Ravindra K. Gupta [Royaume-Uni, Afrique du Sud] | Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis |
| 000049 (2017) |
David I. Dolling [Royaume-Uni] ; Ruth L. Goodall [Royaume-Uni] ; Michael Chirara [Zimbabwe] ; James Hakim [Zimbabwe] ; Peter Nkurunziza [Ouganda] ; Paula Munderi [Ouganda] ; David Eram [Ouganda] ; Dinah Tumukunde [Ouganda] ; Moira J. Spyer [Royaume-Uni] ; Charles F. Gilks [Australie] ; Pontiano Kaleebu [Ouganda] ; David T. Dunn [Royaume-Uni] ; Deenan Pillay [Afrique du Sud] | The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data. |
| 000124 (2017) |
Richard A. Murphy [États-Unis] ; Richard Court [Afrique du Sud] ; Gary Maartens [Afrique du Sud] ; Henry Sunpath [Afrique du Sud] | Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps. |
| 000147 (2017) |
Ruth L. Goodall [Royaume-Uni] ; David T. Dunn [Royaume-Uni] ; Peter Nkurunziza [Ouganda] ; Lincoln Mugarura [Ouganda] ; Theresa Pattery [Belgique] ; Paula Munderi [Ouganda] ; Cissy Kityo [Ouganda] ; Charles Gilks [Australie] ; Pontiano Kaleebu [Ouganda] ; Deenan Pillay [Afrique du Sud] ; Ravindra K. Gupta [Afrique du Sud] | Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa. |
| 000190 (2017) |
Sampson Antwi [Ghana] ; Hongmei Yang [États-Unis] ; Anthony Enimil [Ghana] ; Anima M. Sarfo [Ghana] ; Fizza S. Gillani [États-Unis] ; Daniel Ansong [Ghana] ; Albert Dompreh [Ghana] ; Antoinette Orstin [Ghana] ; Theresa Opoku [Ghana] ; Dennis Bosomtwe [Ghana] ; Lubbe Wiesner [Afrique du Sud] ; Jennifer Norman [Afrique du Sud] ; Charles A. Peloquin [États-Unis] ; Awewura Kwara [États-Unis] | Pharmacokinetics of the First-Line Antituberculosis Drugs in Ghanaian Children with Tuberculosis with or without HIV Coinfection. |
| 000210 (2017) |
John Gregson [Royaume-Uni] ; Pontiano Kaleebu [Ouganda] ; Vincent C. Marconi [États-Unis] ; Cloete Van Vuuren [Afrique du Sud] ; Nicaise Ndembi [Nigeria] ; Raph L. Hamers [Pays-Bas] ; Phyllis Kanki [États-Unis] ; Christopher J. Hoffmann [États-Unis] ; Shahin Lockman [États-Unis] ; Deenan Pillay [Afrique du Sud] ; Tulio De Oliveira [Afrique du Sud] ; Nathan Clumeck [Belgique] ; Gillian Hunt [Afrique du Sud] ; Bernhard Kerschberger [Swaziland] ; Robert W. Shafer [États-Unis] ; Chunfu Yang [États-Unis] ; Elliot Raizes [États-Unis] ; Rami Kantor [États-Unis] ; Ravindra K. Gupta [Afrique du Sud] | Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. |
| 000215 (2017) |
Soo-Yon Rhee [États-Unis] ; Vici Varghese [États-Unis] ; Susan P. Holmes [États-Unis] ; Gert U. Van Zyl [Afrique du Sud] ; Kim Steegen [Afrique du Sud] ; Mark A. Boyd [Australie] ; David A. Cooper [Australie] ; Sabin Nsanzimana [Rwanda] ; Shanmugam Saravanan [Inde] ; Charlotte Charpentier [France] ; Tulio De Oliveira [Afrique du Sud] ; Mary-Ann A. Etiebet [États-Unis] ; Federico Garcia [Espagne] ; Dominique Goedhals [Afrique du Sud] ; Perpetua Gomes [Portugal] ; Huldrych F. Günthard [Suisse] ; Raph L. Hamers [Pays-Bas] ; Christopher J. Hoffmann [États-Unis] ; Gillian Hunt [Afrique du Sud] ; Awachana Jiamsakul [Australie] ; Pontiano Kaleebu [Ouganda] ; Phyllis Kanki [États-Unis] ; Rami Kantor [États-Unis] ; Bernhard Kerschberger [Swaziland] ; Vincent C. Marconi [États-Unis] ; Jean D'Amour Ndahimana [Rwanda] ; Nicaise Ndembi [Nigeria] ; Nicole Ngo-Giang-Huong [France] ; Casper Rokx [Pays-Bas] ; Maria M. Santoro [Italie] ; Jonathan M. Schapiro [Israël] ; Daniel Schmidt [Allemagne] ; Lillian Seu [États-Unis] ; Kim C E. Sigaloff [Pays-Bas] ; Sunee Sirivichayakul [Thaïlande] ; Lindiwe Skhosana [Afrique du Sud] ; Henry Sunpath [Afrique du Sud] ; Michele Tang [États-Unis] ; Chunfu Yang [Haïti] ; Sergio Carmona [Afrique du Sud] ; Ravindra K. Gupta [Royaume-Uni] ; Robert W. Shafer [États-Unis] | Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration. |
| 000308 (2017) |
L Marije Hofstra [Pays-Bas] ; Elena Sánchez Rivas ; Monique Nijhuis [Pays-Bas] ; Leonie E A. Bank [Pays-Bas] ; Eduan Wilkinson [Afrique du Sud] ; Karina Kelly ; Tania Mudrikova [Pays-Bas] ; Rob Schuurman [Pays-Bas] ; Tulio De Oliveira [Afrique du Sud] ; Jaclyn De Kort ; Annemarie M J. Wensing [Pays-Bas] | High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients. |
| 000357 (2017) |
Kerri J. Penrose [États-Unis] ; Carole L. Wallis [Afrique du Sud] ; Chanson J. Brumme [Canada] ; Kristen A. Hamanishi [États-Unis] ; Kelley C. Gordon [États-Unis] ; Raquel V. Viana [Afrique du Sud] ; P Richard Harrigan [Canada] ; John W. Mellors [États-Unis] ; Urvi M. Parikh [États-Unis] | Frequent Cross-Resistance to Dapivirine in HIV-1 Subtype C-Infected Individuals after First-Line Antiretroviral Therapy Failure in South Africa. |
| 000481 (2017) |
Mark A. Boyd [Australie] ; Janaki Amin [Australie] ; Patrick W G. Mallon [Irlande (pays)] ; Nagalingeswaran Kumarasamy [Inde] ; Johan Lombaard [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Ploenchan Chetchotisakd [Thaïlande] ; Praphan Phanuphak [Thaïlande] ; Lerato Mohapi [Afrique du Sud] ; Iskandar Azwa [Malaisie] ; Waldo H. Belloso [Argentine] ; Jean-Michel Molina [France] ; Jennifer Hoy [Australie] ; Cecilia L. Moore [Australie] ; Sean Emery [Australie] ; David A. Cooper [Australie] | Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. |
| 000509 (2017) |
Chukwuemeka Anoje [Nigeria] ; Kenneth Anene Agu [Nigeria] ; Edward A. Oladele [Nigeria] ; Titilope Badru [Nigeria] ; Oluwasanmi Adedokun [Nigeria] ; Dorothy Oqua [Nigeria] ; Hadiza Khamofu [Nigeria] ; Olufunso Adebayo [Nigeria] ; Kwasi Torpey [Nigeria] ; Otto Nzapfurundi Chabikuli [Afrique du Sud] | Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals. |
| 000521 (2017) |
Onyemata E. James [Nigeria] ; Ledwaba Johanna [Afrique du Sud] ; Datir Rawlings [Nigeria] ; M. Babajehson [Nigeria] ; Ismail Ashrad [Afrique du Sud] ; Derache Anne [Afrique du Sud] ; Alash'Le Abimiku [Nigeria] ; Patrick Dakum [Nigeria] ; Hunt Gillian [Afrique du Sud] ; Nicaise Ndembi [Nigeria] | A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria. |
| 000653 (2015) |
Graeme Meintjes [Afrique du Sud, Royaume-Uni] ; Liezl Dunn [Afrique du Sud] ; Marla Coetsee [Afrique du Sud] ; Michael Hislop [Afrique du Sud] ; Rory Leisegang [Afrique du Sud] ; Leon Regensberg [Afrique du Sud] ; Gary Maartens [Afrique du Sud] | Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study |
| 000749 (2014) |
Vincent Okungu [Kenya, Afrique du Sud] ; Lucy Gilson [Afrique du Sud, Royaume-Uni] | “…still waiting for chloroquine”: the challenge of communicating changes in first-line treatment policy for uncomplicated malaria in a remote Kenyan district |
| 000895 (2013) |
Gilles Wandeler [Afrique du Sud] ; Thomas Gsponer ; Lloyd Mulenga ; Daniela Garone ; Robin Wood ; Mhairi Maskew ; Hans Prozesky ; Christopher Hoffmann ; Jochen Ehmer ; Diana Dickinson ; Mary-Ann Davies ; Matthias Egger ; Olivia Keiser | Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa. |
| 000B22 (2013) |
Peter Bock [Afrique du Sud] ; Geoffrey Fatti ; Ashraf Grimwood | Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral therapy in a South African multicentre cohort. |
| 000D40 (2012) |
Thomas Gsponer [Suisse] ; Maya Petersen [États-Unis] ; Matthias Egger [Suisse, Afrique du Sud] ; Sam Phiri [Suisse] ; Marloes H. Maathuis [Royaume-Uni] ; Andrew Boulle [Afrique du Sud] ; Patrick Musondadf [Zambie] ; Hannock Tweya [Suisse] ; Karin Peter [Royaume-Uni] ; Benjamin H. Chi [Zambie, États-Unis] ; Olivia Keiser [Suisse] | The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring |
| 000D46 (2012) |
Raph L. Hamers [Pays-Bas] ; Kim C. E. Sigaloff [Pays-Bas] ; Annemarie M. Wensing [Pays-Bas] ; Carole L. Wallis [Afrique du Sud] ; Cissy Kityo [Ouganda] ; Margaret Siwale [Zambie] ; Kishor Mandaliya [Kenya] ; Prudence Ive [Afrique du Sud] ; Mariette E. Botes [Afrique du Sud] ; Maureen Wellington [Zimbabwe] ; Akin Osibogun [Nigeria] ; Wendy S. Stevens [Afrique du Sud] ; Tobias F. Rinke De Wit [Pays-Bas] ; Rob Schuurman [Pays-Bas] | Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies |
| 000D50 (2012) |
Raph L. Hamers [Pays-Bas] ; Rob Schuurman [Pays-Bas] ; Kim C. E. Sigaloff [Pays-Bas] ; Carole L. Wallis [Afrique du Sud] ; Cissy Kityo [Ouganda] ; Margaret Siwale [Zambie] ; Kishor Mandaliya [Kenya] ; Prudence Ive [Afrique du Sud] ; Mariette E. Botes [Afrique du Sud] ; Maureen Wellington [Zimbabwe] ; Akin Osibogun [Nigeria] ; Ferdinand W. Wit [Pays-Bas] ; Michèle Van Vugt [Pays-Bas] ; Wendy S. Stevens [Afrique du Sud] ; Tobias F. Rinke De Wit [Pays-Bas] | Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study |
| 000D76 (2011) |
Carole L. Wallis [Afrique du Sud] ; John W. Mellors ; Willem D F. Venter ; Ian Sanne ; Wendy Stevens | Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa. |
| 000E03 (2011) |
Julie H. Levison [États-Unis] ; Catherine Orrell [Afrique du Sud] ; Elena Losina [États-Unis] ; Zhigang Lu [États-Unis] ; Kenneth A. Freedberg [États-Unis] ; Robin Wood [Afrique du Sud] | Early outcomes and the virologic impact of delayed treatment switching on second-line therapy in an antiretroviral roll-out program in South Africa |
